Apellis Pharmaceuticals Common
(APLS)
|
13.7 |
$1.0B |
|
11M |
91.10 |
Horizon Therapeutics Common
|
9.8 |
$720M |
|
7.0M |
102.85 |
United Therapeutics Corp Common
(UTHR)
|
8.7 |
$642M |
|
2.9M |
220.75 |
Sarepta Therapeutics Common
(SRPT)
|
7.2 |
$530M |
|
4.6M |
114.52 |
Argenx Se Sponsored ADR
(ARGX)
|
6.7 |
$492M |
|
1.3M |
389.73 |
Madrigal Pharmaceuticals Common
(MDGL)
|
4.7 |
$350M |
|
1.5M |
231.00 |
Biomarin Pharmaceutical Common
(BMRN)
|
4.7 |
$347M |
|
4.0M |
86.68 |
Amicus Therapeutics Common
(FOLD)
|
4.7 |
$344M |
|
27M |
12.56 |
Seagen Common
|
4.6 |
$339M |
|
1.8M |
192.46 |
Ascendis Pharma Sponsored ADR
(ASND)
|
4.3 |
$320M |
|
3.6M |
89.25 |
Iveric Bio Common
|
4.3 |
$317M |
|
8.1M |
39.34 |
Krystal Biotech Common
(KRYS)
|
4.1 |
$301M |
|
2.6M |
117.40 |
Alnylam Pharmaceuticals Common
(ALNY)
|
2.8 |
$210M |
|
1.1M |
189.94 |
Mirati Therapeutics Common
|
2.7 |
$201M |
|
5.6M |
36.13 |
Xenon Pharmaceuticals Common
(XENE)
|
2.6 |
$189M |
|
4.9M |
38.50 |
Cymabay Therapeutics Common
|
1.5 |
$113M |
|
10M |
10.95 |
Dice Therapeutics Common
|
1.4 |
$102M |
|
2.2M |
46.46 |
Kymera Therapeutics Common
(KYMR)
|
1.2 |
$89M |
|
3.9M |
22.99 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
1.2 |
$88M |
|
1.7M |
51.00 |
Biocryst Pharmaceuticals Common
(BCRX)
|
1.2 |
$85M |
|
12M |
7.04 |
Nuvalent Common
(NUVL)
|
0.9 |
$68M |
|
1.6M |
42.17 |
Roivant Sciences Common
(ROIV)
|
0.8 |
$59M |
|
5.8M |
10.08 |
Syndax Pharmaceuticals Common
(SNDX)
|
0.8 |
$56M |
|
2.7M |
20.93 |
Iovance Biotherapeutics Common
(IOVA)
|
0.6 |
$47M |
|
6.7M |
7.04 |
Mannkind Corp Common
(MNKD)
|
0.5 |
$37M |
|
9.1M |
4.07 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.5 |
$35M |
|
750k |
46.13 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.5 |
$34M |
|
3.2M |
10.86 |
Kura Oncology Common
(KURA)
|
0.4 |
$33M |
|
3.1M |
10.58 |
Monte Rosa Therapeutics Common
(GLUE)
|
0.4 |
$31M |
|
4.5M |
6.85 |
Avidity Biosciences Common
(RNA)
|
0.4 |
$28M |
|
2.5M |
11.09 |
Design Therapeutics Common
(DSGN)
|
0.3 |
$22M |
|
3.5M |
6.30 |
Mersana Therapeutics Common
(MRSN)
|
0.3 |
$21M |
|
6.4M |
3.29 |
Aadi Biosciences Common
(AADI)
|
0.3 |
$20M |
|
2.8M |
6.84 |
Pmv Pharmaceuticals Common
(PMVP)
|
0.3 |
$19M |
|
3.1M |
6.26 |
Verrica Pharmaceuticals Common
(VRCA)
|
0.2 |
$17M |
|
3.0M |
5.77 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.2 |
$13M |
|
357k |
35.66 |
Seres Therapeutics Common
(MCRB)
|
0.2 |
$12M |
|
2.5M |
4.79 |
Ikena Oncology Common
(IKNA)
|
0.1 |
$11M |
|
1.6M |
6.56 |
Fennec Pharmaceuticals Common
(FENC)
|
0.1 |
$11M |
|
1.2M |
8.83 |
Tango Therapeutics Common
(TNGX)
|
0.1 |
$5.4M |
|
1.6M |
3.32 |
Io Biotech Common
(IOBT)
|
0.1 |
$4.0M |
|
2.1M |
1.96 |
Talaris Therapeutics Common
|
0.0 |
$1.5M |
|
500k |
3.04 |
Aeglea Biotherapeutics Common
|
0.0 |
$129k |
|
287k |
0.45 |